RE: News10 Aug 2021 20:59
dallo, Have to agrree with most of what you said , however one must emphasize that ,imo , it’s very unusual for the fda to ask for further pharmacokinetics assay studies at this late stage , it’s certainly the first time I have seen this .
Given Lupuzor’s safety record , I was not expecting any objections from the FDA whatsoever...but here we are , still awaiting the green light ...